Royce & Associates’s Embecta EMBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.08M Buy
639,378
+575,818
+906% +$3.14M 0.02% 604
2026
Q1
$562K Buy
63,560
+26,589
+72% +$277K 0.01% 694
2025
Q4
$439K Buy
36,971
+8,682
+31% +$114K ﹤0.01% 717
2025
Q3
$399K Buy
28,289
+6,589
+30% +$83.3K ﹤0.01% 719
2025
Q2
$210K Sell
21,700
-26,062
-55% -$293K ﹤0.01% 755
2025
Q1
$609K Sell
47,762
-6,016
-11% -$96.3K 0.01% 717
2024
Q4
$1.11M Sell
53,778
-15,409
-22% -$253K 0.01% 712
2024
Q3
$976K Sell
69,187
-821
-1% -$11.9K 0.01% 732
2024
Q2
$875K Sell
70,008
-17,293
-20% -$210K 0.01% 730
2024
Q1
$1.16M Sell
87,301
-24,856
-22% -$385K 0.01% 707
2023
Q4
$2.12M Buy
112,157
+2,699
+2% +$44.3K 0.02% 637
2023
Q3
$1.65M Buy
109,458
+11,359
+12% +$213K 0.02% 674
2023
Q2
$2.12M Buy
98,099
+1,494
+2% +$40.7K 0.02% 658
2023
Q1
$2.72M Buy
96,605
+57,814
+149% +$1.64M 0.03% 615
2022
Q4
$981K Buy
38,791
+17,441
+82% +$533K 0.01% 758
2022
Q3
$615K Buy
+21,350
New +$632K 0.01% 795

Other funds holding EMBC

Royce & Associates's EMBC Position: Q2 2026 in Review

Royce & Associates increased its Embecta (EMBC) stake by 906% in Q2 2026, buying an estimated $3.14M and bringing the position to 639,378 shares worth $2.08M. The position accounts for 0.02% of the portfolio, ranked #604.

Royce & Associates first reported a position in EMBC in Q3 2022 and has held it in 16 quarters since. The position peaked at $2.72M in Q1 2023. 320 funds tracked by Wall St. Rank hold EMBC as of Q2 2026.

  • Royce & Associates held 639,378 shares of Embecta worth $2.08M as of Q2 2026.
  • Royce & Associates bought 575,818 Embecta shares in Q2 2026, an estimated $3.14M.
  • Embecta made up 0.02% of Royce & Associates's portfolio in Q2 2026, its #604 holding.
  • Royce & Associates first reported a position in Embecta in Q3 2022 and has held it in 16 quarters since.
  • Royce & Associates's Embecta position peaked at $2.72M in Q1 2023.
  • 320 funds tracked by Wall St. Rank held Embecta as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.